Gold R
Faculty of Medicine, University of Toronto, Ontario, Canada.
Drugs. 1988;36 Suppl 4:1-5. doi: 10.2165/00003495-198800364-00003.
Acute infectious diarrhoea is the major killer of children in the Third World. It is also the principal cause of malnutrition in children under 5 years of age. More than 4 million children die each year of diarrhoea and its complications. Acute diarrhoea kills by causing dehydration, which leads to hypovolaemia and metabolic acidosis. Recurrent episodes of diarrhoea lead to malnutrition as the result of anorexia, catabolism from infection, and lack of adequate caloric and protein intake because of the widespread custom of 'starving' diarrhoea. Oral rehydration therapy (ORT) is effective in the prevention and treatment of dehydration caused by diarrhoea. Because it is cheap, easy to administer and very effective, ORT has the potential to allow substantial reductions in the morbidity and mortality of acute diarrhoea in children living in less developed countries. The major obstacles to achieving its potential are the social ones of production and distribution of oral rehydration solutions and of educating parents in how to use ORT.
急性感染性腹泻是第三世界儿童的主要杀手。它也是5岁以下儿童营养不良的主要原因。每年有超过400万儿童死于腹泻及其并发症。急性腹泻通过导致脱水致人死亡,脱水会引发低血容量和代谢性酸中毒。腹泻反复发作会导致营养不良,这是由于厌食、感染引起的分解代谢以及因普遍存在的“饿治”腹泻习俗而导致热量和蛋白质摄入不足所致。口服补液疗法(ORT)在预防和治疗腹泻引起的脱水方面很有效。由于其价格低廉、易于实施且非常有效,口服补液疗法有潜力大幅降低欠发达国家儿童急性腹泻的发病率和死亡率。实现其潜力的主要障碍是社会方面的,包括口服补液溶液的生产和分发以及教育家长如何使用口服补液疗法。